首页> 外文期刊>Journal of land use science >Associations between thromboxane A synthase 1 gene polymorphisms and the risk of ischemic stroke in a Chinese Han population
【24h】

Associations between thromboxane A synthase 1 gene polymorphisms and the risk of ischemic stroke in a Chinese Han population

机译:血栓素1基因多态性的梭菌与中国汉族人群中缺血性卒中风险的关联

获取原文
获取原文并翻译 | 示例
           

摘要

Thromboxane A synthase 1 (TBXAS1) catalyses the synthesis of thromboxane A2 (TXA2), which plays an important role in the pathogenesis of ischemic stroke. Thus, the TBXAS1 gene was investigated as a candidate gene involved in the formation of atherosclerosis. This case-control study collected peripheral blood specimens and clinical data of 370 ischemic stroke patients and 340 healthy controls in the Northern Chinese Han population from October 2010 to May 2011. Two TBXAS1 single-nucleotide polymorphisms, rs2267682 and rs10487667, were analyzed using a SNaPshot Multiplex sequencing assay to explore the relationships between the single-nucleotide polymorphisms in TBXAS1 and ischemic stroke. The TT genotype frequency and T allele frequency of rs2267682 in the patients with ischemic stroke were significantly higher than those in the controls (P 0.01 and P = 0.02). Furthermore, compared with the GG + GT genotype, the TT rs2267682 genotype was associated with increased risk of ischemic stroke (odds ratio (OR) = 1.80, 95% confidence interval (CI): 1.16-2.79, P 0.01). Multivariate logistic analysis with adjustments for confounding factors revealed that rs2267682 was still associated with ischemic stroke (OR = 1.94, 95% CI : 1.13-3.33, P = 0.02). The frequency of the T-G haplotype in the patients was significantly higher than that in the controls according haplotype analysis (OR = 1.49, 95% CI: 1.10-2.00, P 0.01). These data reveal that the rs2267682 TBXAS1 polymorphism is associated with ischemic stroke. The TT genotype of TBXAS1 and T allele of rs2267682 increase susceptibility to ischemic stroke in this Northern Chinese Han population. The protocol has been registered with the Chinese Clinical Trial Registry (registration number: ChiCTR-COC-17013559).
机译:血栓素1(TBXAS1)催化血栓素A2(TXA2)的合成,其在缺血性卒中的发病机制中起着重要作用。因此,研究了TBXAS1基因作为参与形成动脉粥样硬化的候选基因。本病例对照研究收集了从2010年10月到2011年10月到2010年10月到2010年10月的370名缺血性中风患者的外周血样本和340例健康对照组。使用快照分析了两种TBXAS1单核苷酸多态性,RS2267682和RS10487667多重测序测定以探讨TBXAS1和缺血性卒中中单核苷酸多态性之间的关系。缺血性卒中患者的TT基因型频率和T等位基因频率明显高于对照中的患者(P <0.01和P = 0.02)。此外,与GG + GT基因型相比,TT RS2267682基因型与缺血性卒中的风险增加有关(OTS比(或)= 1.80,95%置信区间(CI):1.16-2.79,P <0.01)。多变量逻辑分析随着混淆因素的调整显示,RS2267682仍然与缺血性卒中(或= 1.94,95%CI:1.13-3.33,P = 0.02)相关。根据单倍型分析(或= 1.49,95%CI:1.10-2.00,P <0.01),患者T-G单倍型的频率显着高于对照中的对照中的频率。这些数据表明,RS2267682 Tbxas1多态性与缺血性卒中有关。 TBXAs1和T等位基因的TT基因型为荷兰省北方汉族人口缺血中风的易感性增加。该协议已在中国临床试验登记处注册(注册号:CHICTR-COC-17013559)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号